UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge

Schizophrenia research, 2020-06, Vol.220, p.265-266

2020

Volltextzugriff (PDF)

Worldwide Differences in Regulations of Clozapine Use

CNS drugs, 2016-02, Vol.30 (2), p.149-161

2016

Volltextzugriff (PDF)

Association between Inflammation and Thrombotic Pathway Link with Pathogenesis of Depression and Anxiety in SLE Patients

Biomolecules (Basel, Switzerland), 2023-03, Vol.13 (3), p.567

2023

Volltextzugriff (PDF)

Anticancer Activity of Toxins from Bee and Snake Venom-An Overview on Ovarian Cancer

Molecules (Basel, Switzerland), 2018-03, Vol.23 (3), p.692

2018

Volltextzugriff (PDF)

Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN)

Frontiers in psychiatry, 2021-12, Vol.12, p.767756-767756

2021

Volltextzugriff (PDF)

Dextromethorphan/Bupropion: A Novel Treatment for Patients With Major Depressive Disorder

American journal of therapeutics, 2024-01, Vol.31 (1), p.e24

2024

Volltextzugriff (PDF)

Brain Abnormalities in Schizophrenia: A Comparative Imagistic Study

Medicina (Kaunas, Lithuania), 2024-04, Vol.60 (4), p.564

2024

Volltextzugriff (PDF)

Prevention of Catatonia With Olanzapine Long-Acting Injectable

American journal of therapeutics, 2017-09, Vol.24 (5), p.e599

2017

Volltextzugriff (PDF)

Royal Jelly and Fermented Soy Extracts-A Holistic Approach to Menopausal Symptoms That Increase the Quality of Life in Pre- and Post-menopausal Women: An Observational Study

Nutrients, 2024-02, Vol.16 (5), p.649

2024

Volltextzugriff (PDF)

Cerebral Computed Tomographic Findings in Schizophrenia: Relationship to Second-Generation Antipsychotics and Hyperprolactinemia

Healthcare (Basel), 2024-07, Vol.12 (13), p.1343

2024

Volltextzugriff (PDF)

Clozapine for Treatment-Refractory Aggressive Behavior

Psychiatric quarterly, 2021-06, Vol.92 (2), p.721-733

2021

Volltextzugriff (PDF)

Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania

Healthcare (Basel), 2022-07, Vol.10 (7), p.1265

2022

Volltextzugriff (PDF)

C-Reactive Protein and T3: New Prognostic Factors in Acute Ischemic Stroke

Journal of stroke and cerebrovascular diseases, 2018-10, Vol.27 (10), p.2731-2737

2018

Volltextzugriff (PDF)

Switch from Olanzapine Long-Acting Injectable to its Oral Equivalent during COVID-19 Pandemic: a Real World Observational Study

Psychiatric quarterly, 2022-06, Vol.93 (2), p.627-635

2022

Volltextzugriff (PDF)

One-Year Outcomes for Depression and Anxiety in SLE Patients

Biomedicines, 2024-02, Vol.12 (3), p.484

2024

Volltextzugriff (PDF)

Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature

BMC psychiatry, 2017-08, Vol.17 (1), p.311-311, Article 311

2017

Volltextzugriff (PDF)

Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics-An Observational Study

Brain sciences, 2023-01, Vol.13 (2), p.173

2023

Volltextzugriff (PDF)

WHODAS Assessment Feasibility and Mental Health Impact on Functional Disability in Systemic Lupus Erythematosus

Healthcare (Basel), 2022-06, Vol.10 (6), p.1053

2022

Volltextzugriff (PDF)

Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients

Schizophrenia research, 2014-05, Vol.155 (1), p.72-76

2014

Volltextzugriff (PDF)

Rapid clozapine titration in treatment-refractory bipolar disorder

Journal of affective disorders, 2014-09, Vol.166, p.168-172

2014

Volltextzugriff (PDF)

Reducing Restraint With Clozapine in Involuntarily Admitted Patients With Schizophrenia

American journal of therapeutics, 2017-03, Vol.24 (2), p.e222

2017

Volltextzugriff (PDF)

A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer Dementia

American journal of therapeutics, 2020-05, Vol.27 (3), p.e249

2020

Volltextzugriff (PDF)

Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection

Neuropsychiatric disease and treatment, 2022-01, Vol.18, p.977-983

2022

Volltextzugriff (PDF)

Clozapine for Treatment-Refractory Behavioral Disturbance in Dementia

American journal of therapeutics, 2018-05, Vol.25 (3), p.e320

2018

Volltextzugriff (PDF)

Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment

Neuropsychiatric disease and treatment, 2021-01, Vol.17, p.3053-3060

2021

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)
Berichte
(1)

Sprache

Englisch
(44)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge

Worldwide Differences in Regulations of Clozapine Use

Association between Inflammation and Thrombotic Pathway Link with Pathogenesis of Depression and Anxiety in SLE Patients

Anticancer Activity of Toxins from Bee and Snake Venom-An Overview on Ovarian Cancer

Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN)

Dextromethorphan/Bupropion: A Novel Treatment for Patients With Major Depressive Disorder

Brain Abnormalities in Schizophrenia: A Comparative Imagistic Study

Prevention of Catatonia With Olanzapine Long-Acting Injectable

Royal Jelly and Fermented Soy Extracts-A Holistic Approach to Menopausal Symptoms That Increase the Quality of Life in Pre- and Post-menopausal Women: An Observational Study

Cerebral Computed Tomographic Findings in Schizophrenia: Relationship to Second-Generation Antipsychotics and Hyperprolactinemia

Clozapine for Treatment-Refractory Aggressive Behavior

Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania

C-Reactive Protein and T3: New Prognostic Factors in Acute Ischemic Stroke

Switch from Olanzapine Long-Acting Injectable to its Oral Equivalent during COVID-19 Pandemic: a Real World Observational Study

One-Year Outcomes for Depression and Anxiety in SLE Patients

Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature

Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics-An Observational Study

WHODAS Assessment Feasibility and Mental Health Impact on Functional Disability in Systemic Lupus Erythematosus

Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients

Rapid clozapine titration in treatment-refractory bipolar disorder

Reducing Restraint With Clozapine in Involuntarily Admitted Patients With Schizophrenia

A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer Dementia

Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection

Clozapine for Treatment-Refractory Behavioral Disturbance in Dementia

Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment

Suchergebnisse filtern